Drug Type Small molecule drug |
Synonyms Compound 18(Arkuda Therapeutics) |
Target |
Mechanism TRPML1 agonists(mucolipin 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Arkuda Therapeutics, Inc.Startup |
Active Organization Arkuda Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H25ClN6 |
InChIKeySHVDVVSAIFSYNO-UQCOIBPSSA-N |
CAS Registry3040015-42-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | Arkuda Therapeutics, Inc.Startup | 15 Jan 2024 |